NCT00239083View on ClinicalTrials.gov

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Kidney Transplantation

Interventions

DRUG

Enteric-Coated Mycophenolate Sodium (EC-MPS)

Trial Locations (1)

Unknown

Novartis, Basel

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY